JPS53101395A - Desacetyl 890a10 - Google Patents

Desacetyl 890a10

Info

Publication number
JPS53101395A
JPS53101395A JP1527878A JP1527878A JPS53101395A JP S53101395 A JPS53101395 A JP S53101395A JP 1527878 A JP1527878 A JP 1527878A JP 1527878 A JP1527878 A JP 1527878A JP S53101395 A JPS53101395 A JP S53101395A
Authority
JP
Japan
Prior art keywords
desacetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1527878A
Other languages
English (en)
Japanese (ja)
Inventor
Esu Keehan Jiin
Emu Keehan Furederitsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS53101395A publication Critical patent/JPS53101395A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP1527878A 1977-02-11 1978-02-13 Desacetyl 890a10 Pending JPS53101395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76772377A 1977-02-11 1977-02-11

Publications (1)

Publication Number Publication Date
JPS53101395A true JPS53101395A (en) 1978-09-04

Family

ID=25080357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1527878A Pending JPS53101395A (en) 1977-02-11 1978-02-13 Desacetyl 890a10

Country Status (10)

Country Link
JP (1) JPS53101395A (da)
CH (1) CH637960A5 (da)
DE (1) DE2805701A1 (da)
DK (1) DK40578A (da)
ES (1) ES466646A1 (da)
FR (1) FR2380280A1 (da)
GB (1) GB1595234A (da)
IT (1) IT7847912A0 (da)
NL (1) NL7800957A (da)
SE (1) SE7800978L (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7800979L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
NZ190994A (en) 1978-07-24 1981-10-19 Merck & Co Inc Z-2-acylamino-3-monosubstituted propenoates
DE2966187D1 (en) * 1978-08-23 1983-10-27 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK497476A (da) * 1975-11-24 1977-05-25 Merck & Co Inc Fremgangsmade til fremstilling af et antibiotisk stof
SE7800979L (sv) * 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum

Also Published As

Publication number Publication date
ES466646A1 (es) 1980-12-16
FR2380280A1 (fr) 1978-09-08
GB1595234A (en) 1981-08-12
NL7800957A (nl) 1978-08-15
FR2380280B1 (da) 1980-05-16
CH637960A5 (en) 1983-08-31
SE7800978L (sv) 1978-08-12
DK40578A (da) 1978-08-12
DE2805701A1 (de) 1978-08-17
IT7847912A0 (it) 1978-02-03

Similar Documents

Publication Publication Date Title
CS343178A2 (en) Plynova turbina
GB2002346A (en) 6-hydroxyprostaglandins
GB2018711B (en) Microcabsules
JPS53126791A (en) Ophthalmolgic decice
JPS53107794A (en) Abraisives
GB2003859B (en) 4-substituted-pyrazoles
JPS53125886A (en) Multicollimator
GB2013704B (en) Lightstick
JPS5419972A (en) 33indolylltertiary butylaminopropanols
MY8200242A (en) Pyridobenzodiazepines
IL55358A0 (en) 6-deoxyneamines
JPS5416423A (en) Alphaafluoromethyllalphaaaminoalkanoate
GB2001071A (en) Dihydrotriazinlthiooxacephalosporins
JPS53115991A (en) Lathf
GB2001095B (en) Ice-shedding
GB2005971B (en) Tailers
GB2009769A (en) N-tertiarybutyl organosilylamides
JPS5387314A (en) Nn14099substance
JPS5412395A (en) Cephalosporins
JPS53116372A (en) Steroidspirooxazolidine
GB2009145A (en) Didehydro-prostaglandins
AU4216378A (en) Antibiotic-a-40104
IL52121A0 (en) Polyvinylbenzylamine
GB2007228B (en) Tertiaryalcohols
AU4225778A (en) Imino-bridged benzocycloheptapyridines